The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
Natalie E. Nieuwenhuizen(University of Würzburg), Stefan H. E. Kaufmann(Humboldt-Universität zu Berlin)
Cited by 179
Related Papers
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis
|Nature Medicine|2003|539
Differential Organization of the Local Immune Response in Patients with Active Cavitary Tuberculosis or with Nonprogressive Tuberculoma
|The Journal of Infectious Diseases|2005|134
Next-Generation Vaccines Based on Bacille Calmette–Guérin
|Frontiers in Immunology|2018|122
Klinische Pathophysiologie
|Unknown|2006|93